{"pageContent": "Objective: Several therapies for localised prostate cancer (PC) are available; all yield similar survival rates. However, each therapy has significant side effects that can influence patients' health-related quality of life (HRQoL) in the long run.", "metaData": {"source": "Evaluating peer support for prostate cancer: the Prostate Cancer Peer Support Inventory\nhttps://pubmed.ncbi.nlm.nih.gov/15663527/"}}